DelveInsight’s “Menorrhalgia Market Insights, Epidemiology, and Market Forecast-2032“ report delivers an in-depth understanding of the Menorrhalgia, historical and forecasted epidemiology as well as the Menorrhalgia market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Menorrhagia Overview
Menorrhagia is the medical term for menstrual periods with abnormally heavy or prolonged bleeding. Although heavy menstrual bleeding is a common concern, most women don’t experience blood loss severe enough to be defined as menorrhagia. Heavy menstrual bleeding (HMB), previously known as menorrhagia or hypermenorrhea, is a menstrual period with excessively heavy flow. It is a type of abnormal uterine bleeding (AUB). Abnormal uterine bleeding can be caused by structural abnormalities in the reproductive tract, anovulation, bleeding disorders, hormonal issues (such as hypothyroidism) or cancer of the reproductive tract. The initial evaluation aims at determining pregnancy status, menopausal status, and the source of bleeding.
Menorrhagia Epidemiology Insights
-
Menorrhagia is a very common complaint: The prevalence of menorrhagia increases with age, peaking in women aged 30-49 years. 5% of women aged 30-49 years in the UK consult their GP each year due to excessive uterine bleeding.
-
Worldwide, the incidence of women affected by dysfunctional uterine bleeding is estimated to be around 3%-30%. It is more common for cases to occur around menarche when the menstrual cycle initially begins or around menopause when the natural menstrual cycle is nearing its end
The Report Covers the Menorrhalgia Epidemiology Segmented by:
-
Menorrhagia incident cases
-
Menorrhagia prevelant cases
-
Menorrhagia diagnosed cases
-
Menorrhagia treatment cases
Menorrhagia Market Outlook
The Menorrhalgia market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Menorrhalgia market trends by analyzing the impact of current Menorrhalgia therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Menorrhagia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Menorrhalgia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Menorrhalgia market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Menorrhalgia Market
-
Bayer
-
Nobel Pharmaceuticals
-
Abbott
-
Kissei Pharmaceuticals
-
Juniper Pharmaceuticals
And many others
Menorrhagia Therapies Covered and Analyzed in the Report:
-
Meloxicam
-
Diclofenac Potassium
-
Estradiol valerate
-
Lidocaine
-
YAZ
And many others
Learn more about the Key Companies and Emerging Therapies in the Menorrhalgia Market
Table of Contents
-
Key Insights
-
Menorrhagia Introduction
-
Executive Summary of Menorrhalgia
-
Disease Background and Overview
-
Epidemiology and patient population
-
Menorrhagia Emerging Therapies
-
Menorrhagia Market Outlook
-
Market Access and Reimbursement of Therapies
-
Market Drivers
-
Market Barriers
-
Appendix
-
Report Methodology
-
DelveInsight Capabilities
-
Disclaimer
Learn about the detailed offerings of the report @ Menorrhalgia Market Outlook
Related Reports
The “Menorrhalgia Pipeline Insights, 2023” report by DelveInsight outlays comprehensive insights of the present clinical development scenario and growth prospects across the Menorrhalgia market. A detailed picture of the Menorrhalgia pipeline landscape is provided, which includes the disease overview and Menorrhalgia treatment guidelines. The assessment part of the report embraces in-depth Menorrhalgia commercial assessment and clinical assessment of the Menorrhalgia pipeline products from the pre-clinical developmental phase to the marketed phase.
Trending Reports by DelveInsight
-
Adalimumab Biosimilar Market
-
Arbovirus Infection Market
-
Artificial Pancreas Device System Market
-
Dental Equipment Market
-
Gluten Sensitivity Market
-
Hypothyroidism Market
-
Inflammatory Bowel Disease Market
-
Mayus Kinase Jak Inhibitors Market
-
Mild Dry Eye Market
-
Mucopolysaccharidosis Market
-
Oncolytic Virus Cancer Therapy Market
-
Pyoderma Gangrenosum Market
-
Transdermal Drug Delivery Devices Market
-
Intrathecal Pumps Market
-
Hedgehog Pathway Inhibitors Market
-
Yellow Fever Market
-
Laryngeal Cancer Market
-
Female Infertility Market
-
Gender Dysphoria Market
-
Chronic Brain Damage Market
-
Spain Healthcare Outlook Market
-
Malignant Fibrous Histiocytoma Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services